|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
Regional Oncology Research Center
|
5P30CA006973-55
|
$7,069,034
|
$424,142
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,352,849
|
$856,456
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
5P01CA013106-44
|
$4,421,268
|
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$349,312
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,462,501
|
$519,375
|
Glod, John
|
CCR (NCI)
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
2R01CA138962-07
|
$3,124,816
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SEER CORE 2015-01; HHSN261201300015I - EMORY UNIVERSITY; POP 05/01/2015 - 04/30/2
|
261201300015I
|
$2,335,643
|
|
UNKNOWN, UNKNOWN
|
EMORY UNIVERSITY
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
$67,986
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
SEER CORE 2015-01; HHSN261201300016I - LOUISIANA STATE UNIVERSITY HSC; POP 05/01/
|
261201300016I
|
$2,042,330
|
|
UNKNOWN, UNKNOWN
|
LSU HEALTH SCIENCES CENTER
|
|
Clinical and Genetic Studies of Li Fraumeni Syndrome
|
ZIA CP010144 10503
|
$1,976,426
|
$197,643
|
Savage, Sharon
|
DCEG (NCI)
|
|
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-T
|
1U54CA199075-01
|
$1,854,519
|
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
Comparative Modeling of Lung Cancer Prevention and Control Policies
|
1U01CA199284-01
|
$1,751,835
|
|
MEZA, RAFAEL
|
UNIVERSITY OF MICHIGAN
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011642
|
$1,743,859
|
$1,395,088
|
Gilbert, Mark
|
CCR (NCI)
|
|
CENTRAL DATA COLLECTION CENTER (CDCC), WESTAT DUNS 049508120 PI SUNITHA MATHEW,
|
261201100008C
|
$1,716,430
|
|
MATHEW, SUNITHA
|
WESTAT INCORPORATED
|
|
MCKCC-Cornell Center for Translation of Cancer Nanomedicines
|
1U54CA199081-01
|
$1,668,143
|
|
BRADBURY, MICHELLE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$16,528
|
Alter, Blanche
|
DCEG (NCI)
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$1,573,322
|
$267,465
|
Raffeld, Mark
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$138,413
|
Barr, Frederic
|
CCR (NCI)
|
|
BASE PERIOD 09/15/2015 - 09/14/2017 SURVIVORSHIPCONCIERGE: EXTENDING CANCER SURVI
|
261201500013C
|
$1,499,612
|
|
JAIN, PRADUMAN
|
VIGNET, INC.
|
|
SBIR PHASE II AWARD 09/15/2015 - 09/14/2017 PEAKS: VALIDATION OF MOBILE TECHNOLO
|
261201500014C
|
$1,499,277
|
|
ALBINALI, FAHD
|
EVERY FIT, INC.
|
|
SBIR PHASE II AWARD 09/15/2015 - 09/14/2017 INTEGRATIVE PLATFORM FOR PRIMARY CARE
|
261201500015C
|
$1,495,868
|
|
EVERS, KERRY
|
PRO-CHANGE BEHAVIOR SYSTEMS, INC.
|
|
BRP SCIENTIFIC SUPPORT CONTRACT FUNDING: SCIENTIFIC SUPPORT SERVICES FOR THE BEHA
|
261201200028I
|
$1,494,000
|
|
UNKNOWN, UNKNOWN
|
WESTAT INCORPORATED
|
|
SBIR PHASE II AWARD 09/15/2015 - 09/14/2017. LEVERAGING MOBILE BIOSENSORS FOR JUS
|
261201500016C
|
$1,493,232
|
|
PARATE, ABHINAV
|
LUMME, INC.
|
|
Pre-clinical Translational Research Facility
|
ZIC BC 011641
|
$1,395,088
|
$1,395,088
|
Gilbert, Mark
|
CCR (NCI)
|
|
TESTING OF COMBINATION IMMUNO AND CHEMOPREVENTION STRATEGIES FOR LYNCH SYNDROME G
|
261201500039I
|
$1,363,092
|
|
UNKNOWN, UNKNOWN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
2U54CA132384-06A1
|
$1,266,713
|
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
Adult Brain Tumor Consortium (ABTC)
|
5UM1CA137443-09
|
$1,244,620
|
$1,244,620
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
|
1R01CA188943-01A1
|
$1,234,720
|
|
HILDEBRANDT, MICHELLE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Epidemiology of Ovarian Cancer in African-American Women
|
7R01CA142081-06
|
$1,228,381
|
|
SCHILDKRAUT, JOELLEN
|
UNIVERSITY OF VIRGINIA
|
|
Comparative Modeling to Inform Cervical Cancer Control Policies
|
1U01CA199334-01
|
$1,212,678
|
|
KIM, JANE
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
CONTRACT TITLE: TOBACCO CONTROL RESEARCH BRANCH SCIENTIFIC AND TECHNICAL SERVICES
|
261201000043C
|
$1,200,000
|
|
UNKNOWN, UNKNOWN
|
BLH TECHNOLOGIES, INC.
|
|
Controlling Esophageal Cancer: A Collaborative Modeling Approach
|
1U01CA199336-01
|
$1,186,904
|
|
HUR, CHIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,141,540
|
$159,816
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Comparative Biomedical Scientist Training Program
|
ZIG BC 010931
|
$1,140,005
|
$57,000
|
Simpson, R. Mark
|
CCR (NCI)
|
|
Comparative Modeling of Colorectal Cancer: Informing Health Policies and Prioriti
|
1U01CA199335-01
|
$1,111,287
|
|
ZAUBER, ANN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$1,100,630
|
$110,063
|
Westlake, Christopher
|
CCR (NCI)
|
|
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,096,433
|
$87,715
|
Waldmann, Thomas
|
CCR (NCI)
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
1U01CA199252-01
|
$1,080,326
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Clinical development of 18F PET tracer for imaging VEGF receptors
|
4R44CA177247-02
|
$1,016,118
|
|
BACKER, JOSEPH
|
SIBTECH, INC.
|
|
Molecular Chaperones and DNA Replication
|
ZIA BC 008710
|
$1,009,996
|
$101,000
|
Wickner, Sue
|
CCR (NCI)
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$940,327
|
$188,065
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for
|
4R42CA171552-02
|
$924,745
|
|
DESAI, NEIL
|
AADI, LLC
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$206,498
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
|
4R44CA176937-02
|
$903,055
|
|
LING, XIANG
|
CANGET BIOTEKPHARMA, LLC
|
|
Pediatric Oncology Branch Behavioral Science Core
|
ZID BC 011517
|
$865,625
|
$432,813
|
Glod, John
|
CCR (NCI)
|
|
TNF Signaling, Cell Death and Cancer
|
ZIA SC 010376
|
$835,691
|
$584,983
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
Evaluation of Carcinogenic Risks to Humans
|
2U01CA033193-34
|
$828,046
|
|
STRAIF, KURT
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$826,126
|
$536,982
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Systematic identification of oncogenic KRAS synthetic lethal interactions
|
1U01CA199253-01
|
$817,805
|
|
HAHN, WILLIAM
|
BROAD INSTITUTE, INC.
|
Total relevant funding to Brain for this search: $31,085,553
|